- About About
-
Medical
Medical
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
-
Advocacy
Advocacy
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
-
Policy
Policy
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America
- Join Join
-
-
News From Dallas: ASA on the Road
ASA Participates in the National Multiple Sclerosis Society's National Conference!
This week, ASA Executive Director, Steph Sherer, Government Affairs Director, Caren Woodson, and I traveled to Dallas, Texas to attend the annual National Multiple Sclerosis Society's 2007 National Conference in an effort to continue to build a coalition of condition-based groups and expand ASA MS Patients' Union. We staffed our educational outreach exhibit and discussed safe access to marijuana with a receptive audience of people living with MS, their family-members, caregivers, and advocates. We also were afforded the opportunity to broaden our knowledge about both the National MS Society and the innovations in Multiple Sclerosis research and treatment.
The overall reception from conference participants has been very encouraging. Many people remembered us from last year's conference. Others were introduced to medical cannabis as treatment for symptoms associated with MS for the first time. Building on the momentum generated from an article published earlier this year by InsideMS, "Considering Cannabis," We have been introducing several MS Society chapter leaders, members, and staff to the therapeutic benefits of cannabis and it's ability to treat several symptoms associated with MS.
Since ASA participated in last year's conference, the National MS Society has implemented a Cannabis Task Force, led by MS expert, Dr. Alan J. Thompson, to, "review published studies on medical marijuana and make recommendations." Read more about the objectives of the task force in the Considering Cannabis article.
Click here to read more about ASA's Patients' Unions.
Share